Elevated transaminases potentiate the risk for emerging dysglycemia in children with overweight and obesity.
Florian KoutnyRobert SteinWieland KiessDaniel WeghuberAntje KörnerPublished in: Pediatric obesity (2021)
Elevated transaminases are an early predictor for glycemic deterioration. Hence, NAFLD should further be addressed as a risk factor and therapeutic target for the early prevention of type 2 diabetes.